https://www.selleckchem.com/pr....oducts/Bortezomib.ht
https://www.selleckchem.com/pr....oducts/Bortezomib.ht
Scenario Document: A Frameshift Mutation in MSH2 Exon 2 in the Renal system Receiver With Muir-Torre Syndrome. OBJECTIVES Rapidly progressive interstitial lung disease (RP-ILD) with poor prognosis often accompanies anti-melanoma differentiation-associated gene 5 (MDA5)-positive DM. Combined immunosuppressive therapy, including glucocorticoids, calcineurin inhibitors and intravenous cyclophosphamide (IVCY) is reportedly effective in DM with RP-ILD, but some patients remain res
Curtir
Comentario
Compartilhar
